Analysis of NF-𝜿B Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study

Table 1

Demographics of 102 patients with intermediate risk Hodgkin lymphoma treated on the COG-AHOD0031 clinical trial included in TMA analysis.

Demographic	Group	Number
Sex	Male	56
	Female	44
	Unknown	2
Race	Caucasian (including Hispanic)	78
	African-American	10
	Asian	3
	Other	6
	Unknown	5
HL subtype	Nodular sclerosing	85
	Mixed cellularity	8
	Lymphocyte predominant	7
	NOS	2
Response to therapy	Rapid early response (RER)	79
	Slow early response (SER)	20
	Unknown/inevaluable	3
EBV status by LMP1 or EBER	Positive	26
	Negative	76